tirzepatide type 1 diabetes trial cuts risk of by 94% in adults with prediabetes and obesity or overweight, drugmaker says Tirzepatide vs. Semaglutide: What You

Louis Aronne, an obesity medicine physician and director of the Comprehensive Weight Control Center at Weill Cornell Medicine and NewYork-Presbyterian, tells TODAY.com

AOD 9604 is consistently investigated for its potential role in fat metabolism and weight regulation

The medication works by mimicking glucagon-like peptide-1 (GLP-1), a natural hormone that regulates appetite, blood sugar levels, and the rate at which food moves through your digestive system

This risk is heightened in people taking medications like tirzepatide that already lower blood sugar

Clinical Efficacy of Mounjaro The studies done on Mounjaro also highlight its metabolic impact with lower HbA1c thereby putting the patient on a regimen to address diabetes and obesity if the patient has type 2 diabetes

Weight loss science and solutions are changing, Spector said